Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 8
2005 4
2006 10
2007 6
2008 4
2009 5
2010 14
2011 4
2012 8
2013 11
2014 7
2015 13
2016 7
2017 9
2018 7
2019 9
2020 9
2021 9
2022 11
2023 7
2024 14
2025 10
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Pernicious anemia associated with Kabuki syndrome.
Matsushima S, Kato K, Yoshimi A, Yoshiura KI, Tsuchida M. Matsushima S, et al. Among authors: kato k. Pediatr Int. 2022 Jan;64(1):e14960. doi: 10.1111/ped.14960. Pediatr Int. 2022. PMID: 35092638 No abstract available.
A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.
Kodama Y, Nishi M, Sato A, Imamura CK, Deguchi T, Hirakawa A, Kiyokawa N, Ohki K, Shima H, Kato K, Kato M, Kawasaki H, Sakaguchi H, Hiramatsu H, Goto H, Yamamoto S, Ito M, Tanizawa A, Yuza Y, Saito AM, Ogawa C, Taga T, Adachi S, Shimada H. Kodama Y, et al. Among authors: kato k. Br J Haematol. 2025 Jul;207(1):308-311. doi: 10.1111/bjh.20146. Epub 2025 Jun 9. Br J Haematol. 2025. PMID: 40491170 No abstract available.
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.
Yoshikawa T, Ishida H, Watanabe A, Yuza Y, Shima H, Ito M, Sakurai Y, Keino D, Ichimura T, Kato K, Osugi Y, Sunami S, Shinoda K, Imamura T, Koh K, Okimoto Y, Tono C, Shimada H, Tanizawa A. Yoshikawa T, et al. Among authors: kato k. Int J Hematol. 2025 Jul;122(1):117-127. doi: 10.1007/s12185-025-03953-x. Epub 2025 Mar 15. Int J Hematol. 2025. PMID: 40088374 Free PMC article.
Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders.
Kawaguchi K, Umeda K, Miyamoto S, Yoshida N, Yabe H, Koike T, Kajiwara M, Kawaguchi H, Takahashi Y, Ishimura M, Sakaguchi H, Hama A, Cho Y, Sato M, Kato K, Sato A, Kato K, Tabuchi K, Atsuta Y, Imai K. Kawaguchi K, et al. Among authors: kato k. Bone Marrow Transplant. 2023 May;58(5):600-602. doi: 10.1038/s41409-023-01937-1. Epub 2023 Feb 16. Bone Marrow Transplant. 2023. PMID: 36797422 No abstract available.
Pharmacological Characteristics of Extracellular Ca2+ Influx Pathways Responsible for Platelet-Activating Factor-Induced Contractions in Rat Esophagus Smooth Muscle: Involvement of L-Type, Receptor-Operated, and Store-Operated Ca2+ Channels.
Obara K, Takahashi S, Otake M, Fujiwara M, Kato D, Tanaka M, Ura T, Yamashita M, Murata A, Yoshioka K, Kusakabe T, Takahashi K, Kato K, Tanaka Y. Obara K, et al. Among authors: kato k. Biol Pharm Bull. 2025;48(6):932-940. doi: 10.1248/bpb.b25-00233. Biol Pharm Bull. 2025. PMID: 40582844 Free article.
Synthesis of the Proposed Structure of Mohangic Acid C.
Takahashi K, Kudo S, Kawamura K, Kusakabe T, Kikkawa S, Azumaya I, Kato K. Takahashi K, et al. Among authors: kato k. Org Lett. 2022 May 13;24(18):3416-3420. doi: 10.1021/acs.orglett.2c01285. Epub 2022 May 2. Org Lett. 2022. PMID: 35499310
171 results